Search research articles
Contact Us
Filters
Showing results (11-20 of 94) with videos related to
Page
of 10
Sort By:
Expert Opinion on Investigational Drugs
|
August 11, 2012
New therapies in the treatment of melanoma
Diwakar Davar, John Munn Kirkwood
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2024
Tumor-Associated Macrophages in Merkel Cell Carcinoma: Old Balances, New Checks
Ann W Silk, Diwakar Davar
Nature Reviews. Clinical Oncology
|
March 21, 2024
Identification of dynamic microbiota signatures in patients with melanoma receiving ICIs: opportunities and challenges
Saman Maleki Vareki, Diwakar Davar
JAMA Oncology
|
April 26, 2019
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: Understanding the Upside of the Downside of Checkpoint Blockade
Diwakar Davar, John M Kirkwood
Nature Medicine
|
March 10, 2026
Microbiome modulation in cancer immunotherapy
Sumanta K Pal, Diwakar Davar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2024
Tumor-associated Macrophages in Merkel Cell Carcinoma: Old Balances, New Checks
Ann W Silk, Diwakar Davar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2022
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Diwakar Davar, Hassane M Zarour
Methods in Molecular Biology (Clifton, N.J.)
|
September 11, 2019
Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors
Diwakar Davar, Hassane M Zarour
The Journal of Investigative Dermatology
|
February 11, 2015
Unfolding the mutational landscape of human melanoma
Diwakar Davar, Yan Lin, John M Kirkwood
Cellular and Molecular Bioengineering
|
July 10, 2026
Toward a Dual-Axis Model of Microbiome Modulation in Cancer Immunotherapy: Pathobiont Elimination and Functional Ecosystem Restoration
Diwakar Davar, Hassane M Zarour, Giorgio Trinchieri
Page
of 10
Search research articles
Search
Showing results (11-20 of 94) with videos related to
Sort By:
Page
of 10
Expert Opinion on Investigational Drugs
|
August 11, 2012
New therapies in the treatment of melanoma
Diwakar Davar, John Munn Kirkwood
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2024
Tumor-Associated Macrophages in Merkel Cell Carcinoma: Old Balances, New Checks
Ann W Silk, Diwakar Davar
Nature Reviews. Clinical Oncology
|
March 21, 2024
Identification of dynamic microbiota signatures in patients with melanoma receiving ICIs: opportunities and challenges
Saman Maleki Vareki, Diwakar Davar
JAMA Oncology
|
April 26, 2019
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: Understanding the Upside of the Downside of Checkpoint Blockade
Diwakar Davar, John M Kirkwood
Nature Medicine
|
March 10, 2026
Microbiome modulation in cancer immunotherapy
Sumanta K Pal, Diwakar Davar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2024
Tumor-associated Macrophages in Merkel Cell Carcinoma: Old Balances, New Checks
Ann W Silk, Diwakar Davar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2022
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Diwakar Davar, Hassane M Zarour
Methods in Molecular Biology (Clifton, N.J.)
|
September 11, 2019
Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors
Diwakar Davar, Hassane M Zarour
The Journal of Investigative Dermatology
|
February 11, 2015
Unfolding the mutational landscape of human melanoma
Diwakar Davar, Yan Lin, John M Kirkwood
Cellular and Molecular Bioengineering
|
July 10, 2026
Toward a Dual-Axis Model of Microbiome Modulation in Cancer Immunotherapy: Pathobiont Elimination and Functional Ecosystem Restoration
Diwakar Davar, Hassane M Zarour, Giorgio Trinchieri
Page
of 10